Daratumumab, lenalidomide, and dexamethasone in systemic light-chain amyloidosis: High efficacy, relevant toxicity and main adverse effect of gain 1q21
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) Editorial |
| Sprache: | Englisch |
| Veröffentlicht: |
2021
|
| In: |
American journal of hematology
Year: 2021, Jahrgang: 96, Heft: 7, Pages: E253-E257 |
| ISSN: | 1096-8652 |
| DOI: | 10.1002/ajh.26191 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1002/ajh.26191 Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ajh.26191 
|
| Verfasserangaben: | Christoph R. Kimmich, Tobias Terzer, Axel Benner, Timon Hansen, Alexander Carpinteiro, Tobias Dittrich, Kaya Veelken, Anna Jauch, Stefanie Huhn, Marco Basset, Hartmut Goldschmidt, Carsten Müller-Tidow, Stefan O. Schönland, Ute Hegenbart |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1856809447 | ||
| 003 | DE-627 | ||
| 005 | 20240306115304.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230821s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ajh.26191 |2 doi | |
| 035 | |a (DE-627)1856809447 | ||
| 035 | |a (DE-599)KXP1856809447 | ||
| 035 | |a (OCoLC)1425063152 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kimmich, Christoph |e VerfasserIn |0 (DE-588)1075478413 |0 (DE-627)833305042 |0 (DE-576)443499632 |4 aut | |
| 245 | 1 | 0 | |a Daratumumab, lenalidomide, and dexamethasone in systemic light-chain amyloidosis |b High efficacy, relevant toxicity and main adverse effect of gain 1q21 |c Christoph R. Kimmich, Tobias Terzer, Axel Benner, Timon Hansen, Alexander Carpinteiro, Tobias Dittrich, Kaya Veelken, Anna Jauch, Stefanie Huhn, Marco Basset, Hartmut Goldschmidt, Carsten Müller-Tidow, Stefan O. Schönland, Ute Hegenbart |
| 264 | 1 | |c 2021 | |
| 300 | |b Illustrationen | ||
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 21.08.2023 | ||
| 700 | 1 | |a Terzer, Tobias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Benner, Axel |d 1959- |e VerfasserIn |0 (DE-588)106584686X |0 (DE-627)81687221X |0 (DE-576)425536602 |4 aut | |
| 700 | 1 | |a Hansen, Timon |e VerfasserIn |4 aut | |
| 700 | 1 | |a Carpinteiro, Alexander |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dittrich, Tobias |d 1986- |e VerfasserIn |0 (DE-588)1075743141 |0 (DE-627)833664085 |0 (DE-576)444611495 |4 aut | |
| 700 | 1 | |a Veelken, Kaya |d 1988- |e VerfasserIn |0 (DE-588)1155327845 |0 (DE-627)1016744269 |0 (DE-576)501617655 |4 aut | |
| 700 | 1 | |a Jauch, Anna |d 1959- |e VerfasserIn |0 (DE-588)1025525140 |0 (DE-627)722525362 |0 (DE-576)168357496 |4 aut | |
| 700 | 1 | |a Huhn, Stefanie |d 1982- |e VerfasserIn |0 (DE-588)1014984424 |0 (DE-627)705313190 |0 (DE-576)349876436 |4 aut | |
| 700 | 1 | |a Basset, Marco |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 700 | 1 | |a Müller-Tidow, Carsten |d 1968- |e VerfasserIn |0 (DE-588)1015101798 |0 (DE-627)705330230 |0 (DE-576)351197893 |4 aut | |
| 700 | 1 | |a Schönland, Stefan |d 1969- |e VerfasserIn |0 (DE-588)122405226 |0 (DE-627)705896137 |0 (DE-576)293255792 |4 aut | |
| 700 | 1 | |a Hegenbart, Ute |e VerfasserIn |0 (DE-588)1028373708 |0 (DE-627)73062157X |0 (DE-576)35901903X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of hematology |d New York, NY : Wiley-Liss, 1976 |g 96(2021), 7, Seite E253-E257 |h Online-Ressource |w (DE-627)302923349 |w (DE-600)1492749-4 |w (DE-576)094060002 |x 1096-8652 |7 nnas |a Daratumumab, lenalidomide, and dexamethasone in systemic light-chain amyloidosis High efficacy, relevant toxicity and main adverse effect of gain 1q21 |
| 773 | 1 | 8 | |g volume:96 |g year:2021 |g number:7 |g pages:E253-E257 |g extent:5 |a Daratumumab, lenalidomide, and dexamethasone in systemic light-chain amyloidosis High efficacy, relevant toxicity and main adverse effect of gain 1q21 |
| 856 | 4 | 0 | |u https://doi.org/10.1002/ajh.26191 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ajh.26191 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230821 | ||
| 993 | |a Editorial | ||
| 994 | |a 2021 | ||
| 998 | |g 1028373708 |a Hegenbart, Ute |m 1028373708:Hegenbart, Ute |d 910000 |d 910100 |d 50000 |e 910000PH1028373708 |e 910100PH1028373708 |e 50000PH1028373708 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 14 |y j | ||
| 998 | |g 122405226 |a Schönland, Stefan |m 122405226:Schönland, Stefan |d 910000 |d 910100 |d 50000 |e 910000PS122405226 |e 910100PS122405226 |e 50000PS122405226 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 13 | ||
| 998 | |g 1015101798 |a Müller-Tidow, Carsten |m 1015101798:Müller-Tidow, Carsten |d 910000 |d 910100 |e 910000PM1015101798 |e 910100PM1015101798 |k 0/910000/ |k 1/910000/910100/ |p 12 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |e 910000PG102258023X |e 910100PG102258023X |k 0/910000/ |k 1/910000/910100/ |p 11 | ||
| 998 | |g 1014984424 |a Huhn, Stefanie |m 1014984424:Huhn, Stefanie |d 910000 |d 910100 |e 910000PH1014984424 |e 910100PH1014984424 |k 0/910000/ |k 1/910000/910100/ |p 9 | ||
| 998 | |g 1025525140 |a Jauch, Anna |m 1025525140:Jauch, Anna |d 910000 |d 910100 |d 50000 |e 910000PJ1025525140 |e 910100PJ1025525140 |e 50000PJ1025525140 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 8 | ||
| 998 | |g 1155327845 |a Veelken, Kaya |m 1155327845:Veelken, Kaya |d 910000 |d 910100 |e 910000PV1155327845 |e 910100PV1155327845 |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 998 | |g 1075743141 |a Dittrich, Tobias |m 1075743141:Dittrich, Tobias |d 910000 |d 910100 |e 910000PD1075743141 |e 910100PD1075743141 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 106584686X |a Benner, Axel |m 106584686X:Benner, Axel |d 50000 |e 50000PB106584686X |k 0/50000/ |p 3 | ||
| 998 | |g 1075478413 |a Kimmich, Christoph |m 1075478413:Kimmich, Christoph |p 1 |x j | ||
| 999 | |a KXP-PPN1856809447 |e 4368428560 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Christoph R. Kimmich, Tobias Terzer, Axel Benner, Timon Hansen, Alexander Carpinteiro, Tobias Dittrich, Kaya Veelken, Anna Jauch, Stefanie Huhn, Marco Basset, Hartmut Goldschmidt, Carsten Müller-Tidow, Stefan O. Schönland, Ute Hegenbart"]},"language":["eng"],"person":[{"display":"Kimmich, Christoph","given":"Christoph","role":"aut","family":"Kimmich"},{"display":"Terzer, Tobias","given":"Tobias","family":"Terzer","role":"aut"},{"given":"Axel","display":"Benner, Axel","family":"Benner","role":"aut"},{"given":"Timon","display":"Hansen, Timon","role":"aut","family":"Hansen"},{"family":"Carpinteiro","role":"aut","given":"Alexander","display":"Carpinteiro, Alexander"},{"display":"Dittrich, Tobias","given":"Tobias","family":"Dittrich","role":"aut"},{"role":"aut","family":"Veelken","given":"Kaya","display":"Veelken, Kaya"},{"family":"Jauch","role":"aut","given":"Anna","display":"Jauch, Anna"},{"role":"aut","family":"Huhn","given":"Stefanie","display":"Huhn, Stefanie"},{"display":"Basset, Marco","given":"Marco","role":"aut","family":"Basset"},{"given":"Hartmut","display":"Goldschmidt, Hartmut","role":"aut","family":"Goldschmidt"},{"role":"aut","family":"Müller-Tidow","display":"Müller-Tidow, Carsten","given":"Carsten"},{"display":"Schönland, Stefan","given":"Stefan","role":"aut","family":"Schönland"},{"given":"Ute","display":"Hegenbart, Ute","role":"aut","family":"Hegenbart"}],"recId":"1856809447","note":["Gesehen am 21.08.2023"],"title":[{"title_sort":"Daratumumab, lenalidomide, and dexamethasone in systemic light-chain amyloidosis","title":"Daratumumab, lenalidomide, and dexamethasone in systemic light-chain amyloidosis","subtitle":"High efficacy, relevant toxicity and main adverse effect of gain 1q21"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"5 S.","noteIll":"Illustrationen"}],"id":{"eki":["1856809447"],"doi":["10.1002/ajh.26191"]},"relHost":[{"part":{"year":"2021","volume":"96","issue":"7","extent":"5","pages":"E253-E257","text":"96(2021), 7, Seite E253-E257"},"language":["eng"],"note":["Gesehen am 19.11.14"],"pubHistory":["1.1976 -"],"disp":"Daratumumab, lenalidomide, and dexamethasone in systemic light-chain amyloidosis High efficacy, relevant toxicity and main adverse effect of gain 1q21American journal of hematology","type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"302923349","id":{"issn":["1096-8652"],"eki":["302923349"],"doi":["10.1002/(ISSN)1096-8652"],"zdb":["1492749-4"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"American journal of hematology","title":"American journal of hematology"}],"origin":[{"publisher":"Wiley-Liss","dateIssuedDisp":"1976-","dateIssuedKey":"1976","publisherPlace":"New York, NY"}]}],"origin":[{"dateIssuedDisp":"2021","dateIssuedKey":"2021"}]} | ||
| SRT | |a KIMMICHCHRDARATUMUMA2021 | ||